Core Viewpoint - The report highlights the growth and current status of China's plastic products industry, projecting a production increase in the coming years based on statistical data from the National Bureau of Statistics [1]. Industry Summary - In July 2025, China's plastic products production reached 6.69 million tons, marking a year-on-year growth of 1.7% [1]. - From January to July 2025, the cumulative production of plastic products in China was 45.452 million tons, reflecting a cumulative growth of 4.3% [1]. - The report is part of a comprehensive analysis provided by Zhiyan Consulting, which specializes in industry research and consulting services [1].

Market Overview - The Shanghai Composite Index is at 3852.31 points with a decline of -0.21% as of 10:32 AM, and the total trading volume of A-shares is 1,075.764 billion yuan [1] Stocks with Death Cross - A total of 152 A-shares have seen their 5-day moving average cross below the 10-day moving average, indicating potential bearish trends [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Songjing Co., Ltd. (688157) with a distance of -1.61% - Chunguang Technology (603657) with a distance of -1.02% - Pilin Bio (000403) with a distance of -0.93% [1] Detailed Stock Performance - Key stock performances include: - Songjing Co., Ltd. (688157): Today's change is -0.67% with a latest price of 40.09 yuan, which is -3.28% from the 10-day moving average [1] - Chunguang Technology (603657): Today's change is -3.47% with a latest price of 38.70 yuan, which is -6.79% from the 10-day moving average [1] - Pilin Bio (000403): Today's change is -0.52% with a latest price of 17.32 yuan, which is -2.64% from the 10-day moving average [1] Additional Stocks with Notable Changes - Other stocks showing significant changes include: - Jiangsu New Energy (603693): Today's change is -1.38% with a latest price of 12.87 yuan, which is -2.29% from the 10-day moving average [2] - Yongan Pharmaceutical (002365): Today's change is -1.04% with a latest price of 18.11 yuan, which is -1.45% from the 10-day moving average [2] - Mosi Co., Ltd. (001323): Today's change is -1.95% with a latest price of 28.16 yuan, which is -2.96% from the 10-day moving average [2]

| 证券代码：300305 | 证券简称：裕兴股份 | 公告编号：2025-051 | | --- | --- | --- | | 债券代码：123144 | 债券简称：裕兴转债 | | 江苏裕兴薄膜科技股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会召开期间没有增加或变更提案。 2、本次股东大会未发生否决提案。 3、本次股东大会以现场投票和网络投票表决相结合的方式召开。 一、会议通知情况 1、审议通过《关于不再设立监事会及修订<公司章程>的议案》 表决结果：同意 73,134,800 股，占出席会议有表决权股份总数的 99.4731%；反 对 376,900 股，占出席会议有表决权股份总数的 0.5126%；弃权 10,500 股，占出 席会议有表决权股份总数的 0.0143%。 江苏裕兴薄膜科技股份有限公司（以下简称"公司"）关于召开 2025 年第一次临 时股东大会通知的公告（公告编号：2025-050）已于 2025 年 8 月 28 日刊登于中 国证监会指定的创业板信息 ...

关于江苏裕兴薄膜科技股份有限公司 2025 年第一次临时股东大会之法律意见书 杭州市西湖区学院路 77 号 黄龙国际中心 A 座 16 层 邮编：310012 电话：（86-571）2689-8188 传真：（86-571）2689-8189 junhehz@junhe.com 北京君合（杭州）律师事务所 致: 江苏裕兴薄膜科技股份有限公司 北京君合（杭州）律师事务所（以下简称本所）接受江苏裕兴薄膜科技股份 有限公司（以下简称公司）委托，根据《中华人民共和国证券法》（以下简称《证 券法》）、《中华人民共和国公司法》（以下简称《公司法》）、《上市公司股 东会规则（2025 年修订）》（以下简称《股东会规则》）等中华人民共和国（以 下简称中国，为本法律意见书之目的，不包括中国香港特别行政区、中国澳门特 别行政区和台湾省）现行有效的法律、行政法规、规章和规范性文件和现行有效 的《江苏裕兴薄膜科技股份有限公司章程》（以下简称《公司章程》）有关规定， 指派律师出席了公司于 2025 年 9 月 12 日召开的 2025 年第一次临时股东大会（以 下简称本次股东大会），并就本次股东大会相关事项出具本法律意见书。 为出具本 ...

Financial Performance - Yuxing Co., Ltd. reported a net profit decline of 19.14% year-on-year for the first half of 2025, with total revenue of 475 million yuan, down 22.81% compared to the previous year [1] - The company's gross margin was -11.69%, a decrease of 79.08% year-on-year, while the net margin was -26.1%, down 54.37% year-on-year [1] - In Q2 2025, total revenue was 245 million yuan, reflecting a 28.69% decline year-on-year, and the net profit for the quarter was -67.49 million yuan, a 44.57% decrease year-on-year [1] Key Financial Metrics - The company's operating expenses, including sales, management, and financial costs, totaled 46.32 million yuan, representing a 70.26% increase year-on-year, accounting for 9.74% of revenue [1] - The earnings per share (EPS) was -0.33 yuan, down 13.11% year-on-year, and the operating cash flow per share was -0.15 yuan, a significant decrease of 597.58% year-on-year [1] - The company's cash and cash equivalents decreased by 33.95% to 479 million yuan, and accounts receivable fell by 33.09% to 157 million yuan [1] Investment Insights - The company has a weak historical return on invested capital (ROIC), with a median of 4.32% over the past decade, and the worst year being 2024 with an ROIC of -10.39% [3] - The company has been experiencing negative operating cash flow for the past three years, with an average cash flow to current liabilities ratio of -28.62% [3] - A notable fund manager, Miao Weibin from Jinyuan Shun'an Fund, has recently increased holdings in Yuxing Co., indicating some level of confidence despite the company's financial struggles [4]

Group 1 - The company Yuxing Co., Ltd. held its sixth board meeting on August 27, 2025, combining in-person and remote voting methods [1] - The meeting reviewed the proposal to amend the "Board Secretary Work Guidelines" among other documents [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into humans [1] - The article discusses the implications of this breakthrough and the timeline for potential clinical applications [1]

Core Viewpoint - Yuxing Co., Ltd. (300305.SZ) reported a decline in overall production capacity utilization and a decrease in the production and sales volume of polyester films due to multiple factors including capacity release in the polyester film industry, intensified competition, and supply-demand imbalance [1] Company Summary - The overall production capacity utilization of the company remained low during the reporting period [1] - The production and sales volume of polyester films experienced a decline [1] Industry Summary - The polyester film industry is facing challenges such as capacity release, increased competition, and supply-demand imbalance, which are impacting the performance of companies within the sector [1]

江苏裕兴薄膜科技股份有限公司 关于不向下修正裕兴转债转股价格的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示：1、自 2025 年 8 月 7 日至 2025 年 8 月 27 日，江苏裕兴薄膜科技 股份有限公司（以下简称"公司"）股票在任意连续三十个交易日中至少有十五个 交易日的收盘价低于当期转股价格的 85%，已触发"裕兴转债"转股价格向下修正 条款。 2、经公司第六届董事会第十二次会议审议通过，公司董事会决定本次不向下 修正"裕兴转债"转股价格，且自本次董事会审议通过次一交易日起的 3 个月内（即 自 2025 年 8 月 28 日至 2025 年 11 月 27 日），若再次触发"裕兴转债"转股价格向 下修正条款，亦不提出向下修正方案。自本次董事会审议通过次一交易日起满 3 个月之后，若再次触发"裕兴转债"转股价格向下修正条款，届时董事会将决定是 否再次召开会议行使"裕兴转债"转股价格的向下修正权利。 | 证券代码：300305 | 证券简称：裕兴股份 | 公告编号：2025-047 | | --- | --- | --- | | 债券 ...

东海证券股份有限公司 关于江苏裕兴薄膜科技股份有限公司 2025 年半年度持续督导跟踪报告 | 保荐人名称：东海证券股份有限公司 | 被保荐公司简称：裕兴股份 | | --- | --- | | 保荐代表人姓名：王旭骐 | 联系电话：021-20333333 | | 保荐代表人姓名：李磊 | 联系电话：021-20333333 | | 行、新产品小批量 | | --- | | 试验等因素，成本 | | 增加，毛利率下降。 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1、公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2、督导公司建立健全并有效执行规章制度的 | | | 情况 | | | （1）是否督导公司建立健全规章制度（包括 | | | 但不限于防止关联方占用公司资源的制度、 | 是 | | 募集资金管理制度、内控制度、内部审计制 | | | 度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3、募集资金监督情况 | | | （1）查询公司 ...

Group 1 - The company, Yuxing Co., announced that it will hold its first extraordinary general meeting of shareholders on September 12, 2025 [1] - The agenda for the meeting includes the proposal to abolish the supervisory board and amendments to relevant articles [1]